Source: Journal of the American Society of Nephrology. Conference titles: ASN/ISN World Congress of Nephrology. Unidade: FM
Subjects: NEFROPATIAS, GLOMÉRULOS RENAIS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, Clarice Kazue et al. Early temporary with the AT1 blocker Losartan (L), in high dose or associated with Mycophenolate Mofetil (MMF), limits future injury in the remnant kidney. Journal of the American Society of Nephrology. Washington: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 out. 2024. , 2002APA
Fujihara, C. K., Sena, C. R., Carvalho, L. F., Antunes, G. R., Malheiros, D. M. A. C., & Zatz, R. (2002). Early temporary with the AT1 blocker Losartan (L), in high dose or associated with Mycophenolate Mofetil (MMF), limits future injury in the remnant kidney. Journal of the American Society of Nephrology. Washington: Faculdade de Medicina, Universidade de São Paulo.NLM
Fujihara CK, Sena CR, Carvalho LF, Antunes GR, Malheiros DMAC, Zatz R. Early temporary with the AT1 blocker Losartan (L), in high dose or associated with Mycophenolate Mofetil (MMF), limits future injury in the remnant kidney. Journal of the American Society of Nephrology. 2002 ; 13 345A.[citado 2024 out. 17 ]Vancouver
Fujihara CK, Sena CR, Carvalho LF, Antunes GR, Malheiros DMAC, Zatz R. Early temporary with the AT1 blocker Losartan (L), in high dose or associated with Mycophenolate Mofetil (MMF), limits future injury in the remnant kidney. Journal of the American Society of Nephrology. 2002 ; 13 345A.[citado 2024 out. 17 ]